CLINICAL_TRIALS
trial_result
· 2015-10-28
Clinical Trial Update: Bosutinib For Autosomal Dominant Polycystic Kidney Disease [Phase 2]
Summary
A Phase 2 trial of bosutinib for autosomal dominant polycystic kidney disease has completed, and results were posted in October 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Polycystic Kidney, Autosomal Dominant | Phase 2 | Status: COMPLETED | Results posted: 2015-10-28